Market Snapshot
S&P Futures
3,779.5
Dow Futures
30,569
Nasdaq Futures
11,622.75
RedHill Biopharma Ltd.
(NASDAQ:RDHL)
$0.95
$0.11
12.86%
RedHill Biopharma Ltd. Chart
RDHL Stock Price Today
RedHill Biopharma Ltd. (RDHL) stock rallied over 12.86% intraday to trade at $0.95 a share on NASDAQ. The stock opened with a gain of 15.85% at $0.85 and touched an intraday high of $0.87, rising 9.20% against the last close of $0.87. The stock went to a low of $0.82 during the session.
Stock Snapshot
$0.87
Prev. Close
52.23 Million
Market Cap
$0.82
Day Low
$0.85
Open
52.52 Million
Number of Shares
$0.87
Day High
-
P/E ratio
-1.90
EPS (TTM)
0.72
Cash Flow per Share
3.63
Free Float in %
0.25
Book Value
2,458,455
Volume
RedHill Biopharma Ltd. Historical Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| 2022-07-01 | $0.85 | $0.87 | $0.82 | $0.842 | 1,062,500 |
| 2022-06-30 | $0.82 | $0.88 | $0.791 | $0.87 | 1,365,700 |
| 2022-06-29 | $0.9 | $0.91 | $0.83 | $0.85 | 2,407,000 |
| 2022-06-28 | $1.02 | $1.02 | $0.87 | $0.882 | 6,299,400 |
| 2022-06-27 | $0.855 | $1.03 | $0.83 | $1.02 | 11,862,500 |
| 2022-06-24 | $0.86 | $0.876 | $0.762 | $0.82 | 17,107,900 |
| 2022-06-23 | $1.02 | $1.02 | $0.72 | $0.768 | 55,729,900 |
| 2022-06-22 | $0.72 | $0.82 | $0.693 | $0.767 | 3,822,500 |
| 2022-06-21 | $0.691 | $0.719 | $0.655 | $0.676 | 5,129,100 |
| 2022-06-17 | $0.64 | $0.77 | $0.636 | $0.636 | 1,809,300 |
Contact Details
Company Information
Employees-
Beta1.95
Sales or Revenue85.76 Million
5Y Sales Change285.30%
Fiscal Year Ends2021-12-30
SectorHealth Care
IndustryPharmaceuticals
About Company
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its clinical late-stage investigational development programs include RHB-204, which is in Phase 3 study for pulmonary nontuberculous mycobacteria infections; opaganib (Yeliva), an SK2 selective inhibitor, which has completed Phase 2 study to treat patients with SARS-CoV-2 severe COVID-19 pneumonia, in Phase 2 study to treat advanced unresectable cholangiocarcinoma, and in investigator-sponsored Phase 2 study to treat prostate cancer; RHB-107, which is in Phase 2/3 study to treat outpatients infected with COVID-19 disease, and preclinical evaluation study to treat advanced unresectable cholangiocarcinoma, as well as has completed Phase 2 study to treat gastrointestinal and other solid tumors; RHB-104, which is in Phase 3 studies for Crohn's disease; RHB-102 (Bekinda) that is in Phase 3 studies for acute gastroenteritis and gastritis, and has completed Phase 2 studies for irritable bowel syndrome with diarrhea; and RHB-106, an encapsulated formulation for bowel preparation, which is preparing for Phase 2/3 study. RedHill Biopharma Ltd. was incorporated in 2009 and is headquartered in Tel Aviv, Israel.
Frequently Asked Questions
What is the current RedHill Biopharma Ltd. (RDHL) stock price?
RedHill Biopharma Ltd. (NASDAQ: RDHL) stock price is $0.95 as of the last check on Friday, July 1. During the trading session, RDHL stock reached the peak price of $0.87 while $0.82 was the lowest point it dropped to.
RDHL's industry and sector of operation?
The NASDAQ listed RDHL is part of Pharmaceuticals industry that operates in the broader Health Care sector. RedHill Biopharma Ltd. , a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases.
Who are the executives of RDHL?
Mr. Dror Ben-Asher
Co-Founder, Chairman & CEO
Mr. Micha Ben-Chorin
Chief Financial Officer
Mr. Gilead Raday MPhil, MSc
Chief Operating Officer
Mr. Adi Frish
Chief Corp. & Bus. Devel. Officer
What is the RDHL stock price today?
RDHL stock traded closed the last session at $0.842, which is $0.11 or 12.86% lower than its previous close of $0.87. RDHL's current trading price is 53.19% lower than its 52-week high of $11.18 where as its distance from 52-week low of 0.62% is -91.50%.
How many employees does RDHL have?
Number of RDHL employees currently stands at -. RDHL operates from 21 Ha’arba’a Street, Tel Aviv 6473921, Israel.
Link for RDHL official website?
Official Webiste of $RDHL is: https://www.redhillbio.com
How do I contact RDHL?
RDHL could be contacted at RDHL operates from 21 Ha’arba’a Street, Tel Aviv 6473921, Israel, or at phone #972 3 541 3131 and can also be accessed through its website.
How many shares of RDHL are traded daily?
RDHL stock volume for the day was 2,458,455 shares while in the previous session number of RDHL shares traded was 1,062,500 . The average number of RDHL shares traded daily for last 3 months was 2.08 Million.
How much did RDHL change today?
The percentage change in RDHL stock occurred in the recent session was 12.86% while the dollar amount for the price change in RDHL stock was $0.11.
What price range RDHL stock been trading in?
In the recent session, the day high for RDHL stock was $0.87 while the low for RDHL stock touched on the day was $0.82.
What is the market cap of RDHL currently?
The market value of RDHL currently stands at 52.23 Million with its latest stock price at $0.95 and 52.52 Million of its shares outstanding.